Melissa Pezzotti
Papers
2
Total Citations
4
H-Index
2
About
Melissa Pezzotti is a pioneering researcher at the intersection of biomaterials engineering and high-throughput drug discovery. Her work centers on developing physiologically relevant cell culture platforms that bridge the critical gap between traditional plastic-based assays and advanced organoid models. Pezzotti’s major contribution is the creation of HYDRA—a robotic liquid handling automation system for fabricating hydrogel cell culture substrates at scale. This innovation solves a persistent bottleneck in drug development: while hydrogels better mimic native tissue environments, their curved menisci have historically prevented integration with standard high-throughput screening (HTS) plates. By automating hydrogel fabrication, HYDRA enables reproducible, physiologically relevant 3D cultures compatible with existing HTS infrastructure. Though her most-cited papers (2024–2025) currently hold 2 citations each, their impact is rapidly growing as the pharmaceutical industry seeks more predictive preclinical models. Pezzotti’s work promises to enhance drug testing accuracy by combining biomimetic hydrogels with the scalability required for early-stage screening—a dual achievement that positions her at the forefront of next-generation cell culture technology. Her research directly addresses the translational gap between organ-on-chip innovations and industrial-scale drug development.
Research Focus
Key Achievements
Top Papers
- 1
- 2